Have a personal or library account? Click to login
Clinical Features and Disease Course of Cancer Patients Infected with Sars-Cov-2 During Anticancer Treatments Cover

Clinical Features and Disease Course of Cancer Patients Infected with Sars-Cov-2 During Anticancer Treatments

Open Access
|Jan 2024

Authors

Aleksandra Babić

slaville2003@gmail.com

Department of Clinical Oncology, Clinical Hospital Center Zemun, Belgrade, Serbia

Jelena Milin-Lazović

Institute for medical statistics and informatics, Medical Faculty, Belgrade, Serbia

Sanja Milenković

Department of Clinical Pathology, Clinical Hospital Center Zemun, Belgrade, Serbia

Jelena Dobrić

Department of Clinical Oncology, Clinical Hospital Center Zemun, Belgrade, Serbia

Zlata Hufnagel

Department of Clinical Oncology, Clinical Hospital Center Zemun, Belgrade, Serbia

Nenad Miladinović

Department of Clinical Pathology, Clinical Hospital Center Zemun, Belgrade, Serbia

Sofija Milanović

Department of Clinical Oncology, Clinical Hospital Center Zemun, Belgrade, Serbia

Marina Stojanović

Department of Clinical Oncology, Clinical Hospital Center Zemun, Belgrade, Serbia

Sara Filipović

Department of Clinical Oncology, Clinical Hospital Center Zemun, Belgrade, Serbia

Aleksandar Gavrić

Department of Clinical Oncology, Clinical Hospital Center Zemun, Belgrade, Serbia

Nikola Borlja

Centogene AG, Rostock, Germany
DOI: https://doi.org/10.2478/sjecr-2020-0054 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Language: English
Page range: 277 - 287
Submitted on: Oct 6, 2020
|
Accepted on: Nov 30, 2020
|
Published on: Jan 2, 2024
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Aleksandra Babić, Jelena Milin-Lazović, Sanja Milenković, Jelena Dobrić, Zlata Hufnagel, Nenad Miladinović, Sofija Milanović, Marina Stojanović, Sara Filipović, Aleksandar Gavrić, Nikola Borlja, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.